DocWire News Editors

DocwireNews

A longitudinal research study out of an Austrian institute identified several disease-specific and patient-related factors that are associated with poor health-related quality of life (HRQOL) in patients newly diagnosed with myelodysplastic syndromes (MDS). The results were presented at the 62nd ASH Annual Meeting &amp; Exposition.&ldquo;HRQOL, a unique source of patient information, represents a valuable parameter for assessing treatment burden and therapy response in MDS,&rdquo; said author Igor Stojkov, MSc, of the Institute of Public Health, Medical Decision Making, and Health Technology Assessment, based at the University for Health Sciences, Medical Informatics, and Technology in Tirol, Austria. &ldquo;These determinants provide valuable knowledge toward improved personalized treatment approaches and early preventive measures in MDS.&rdquo;The institute analyzed longitudinal data from the European MDS Registry, a prospective, multicenter repository for data on patients newly diagnosed with MDS in 17 countries. The registry includes information from approximately 2,500 patients and continues to add patients.The current study included 2,205 patients who had baseline data within 100 days of diagnosis, as well as two follow-up visits. The study&rsquo;s two primary measurements to determine HRQOL were scores on the EuroQol Five-Dimension Three-Level Index (EQ-5D) and a visual analog scale. It also assessed data from the Karnofsky Performance Index (KPI); Sorror Comorbidity Index; and clinical information such as serum ferritin, hemoglobin, and transfusion variables (dependence, number, and density).The researchers performed multivariate analyses to identify any associations between disease-specific or patient-related parameters and HRQOL. They found that certain characteristics were associated with low HRQOL:<ul>
<li>Age older than 75 years</li>
<li>Comorbidities, as measured by the MDS-Specific Comorbidity Index</li>
<li>Female gender</li>
<li>Low KPI score</li>
<li>Serum ferritin levels &ge;1,000 &mu;g/L</li>
</ul>The researchers also assessed secondary outcomes by evaluating specific dimensions on the EQ-5D:<ul>
<li>Mobility</li>
<li>Self-care</li>
<li>Usual activities</li>
<li>Pain and discomfort</li>
<li>Anxiety and depression</li>
</ul>About 10% to 11% of patients reported impairment in the dimension self-care, and about 30% of patients reported impairment in the other four EQ-5D dimensions. Specifically, female gender, low KPI score, low Sorror Comorbidity Index score, low hemoglobin count, and transfusion-related variables were major determinants of impairment in all five dimensions. On the other hand, higher hemoglobin levels and higher KPI scores were associated with better HRQOL.Mr. Stojkov said the institute is currently conducting studies to evaluate HRQOL and specific interventions.

MarkAlain Déry, DO

Eric Griggs, MD

Measles in America: An Ongoing Problem

Infectious Disease

Roger Rodby, MD

Joel M. Topf, MD, FACP

Seldin Award Winner Advocates Online Education

NKF Spring Clinical Meetings 2025

Hatem Soliman, MD

The Future of Dendritic Cell Vaccines in HER2+ Breast Cancer: Toward De-Escalation of Chemotherapy

HER2 Breast Cancer

Latest News

Study Identifies Factors That Impact Health-Related Quality of Life in Patients With MDS

ASH Annual Meeting 2020

A longitudinal research study out of an Austrian institute identified several disease-specific and patient-related factors that are associated with poor health-related quality ...

Study Identifies Factors That Impact Health-Related Quality of Life in Patients with MDS

About Us

Editorial Policy

Advertising

Contact Us

eNewsletters

Contribute

Career Center

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Bile Duct Cancer

Colorectal Cancer

Gastroesophageal Cancer

Gastric Cancer

GEP-NETs

GIST

Liver Cancer

Pancreatic Cancer

GI Oncology Now

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Hemophilia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Anemia and Kidney Disease

Chronic Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

Nephrology Times

HR Breast Cancer

Triple-Negative Breast Cancer

Genetics & Breast Cancer

Breast Cancers Today

Atherosclerotic Disease

Atrial Fibrillation

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Cardiology

Breast Cancer

Gynecologic Cancer

Head and Neck Cancer

Skin Cancer

Oncology

Sleep

Urology

Diabetes

Ophthalmology

— Demodex Blepharitis

Neurology

Rheumatology

Gastroenterology

Pulmonology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Future of Medicine

Orthopedics

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

Rheumatology Rounds With Dr. Maheswaranathan

Partners

Expert Interviews

Subscribe